Clinical trial
Controlling Rapid Atrial Fibrillation With Dexmedetomidine (C-RAD) Trial
NCT04042727 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Controlling Rapid Atrial Fibrillation With Dexmedetomidine (C-RAD) Trial
- Lead sponsor
- Stony Brook University
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- August 21, 2019
- Completion date
- December 31, 2021
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart rate control, rapid atrial fibrillation